When.com Web Search

  1. Ads

    related to: subcutaneous injection sites landmarks for glucagon treatment of hypertension

Search results

  1. Results From The WOW.Com Content Network
  2. Subcutaneous administration - Wikipedia

    en.wikipedia.org/wiki/Subcutaneous_administration

    Subcutaneous injection sites. Commonly used injection sites include: [3]: 723 The outer area of the upper arm. The abdomen, avoiding a 2-inch circle around the navel. The front of the thigh, between 4 inches from the top of the thigh and 4 inches above the knee. The upper back. The upper area of the buttock, just behind the hip bone.

  3. Teduglutide - Wikipedia

    en.wikipedia.org/wiki/Teduglutide

    Teduglutide, sold under the brand names Revestive (EU) and Gattex (US), is a 33-membered polypeptide and glucagon-like peptide-2 (GLP-2) analog that is used for the treatment of short bowel syndrome. It works by promoting mucosal growth and possibly restoring gastric emptying and secretion. [ 7 ]

  4. Glucagon (medication) - Wikipedia

    en.wikipedia.org/wiki/Glucagon_(medication)

    An injectable form of glucagon may be part of first aid in cases of low blood sugar when the person is unconscious or for other reasons cannot take glucose orally or by intravenous. [15] The glucagon is given by intramuscular, intravenous or subcutaneous injection, and quickly raises blood glucose levels. To use the injectable form, it must be ...

  5. Skin popping - Wikipedia

    en.wikipedia.org/wiki/Skin_popping

    It is usually a depot injection, either subcutaneous or intradermal, and not an intramuscular injection. After deposition, the drug then diffuses slowly from the depot into the capillary networks, where it enters circulation. Skin popping is distinct from intravenous injection in that the latter deposits the drug directly into the bloodstream ...

  6. Glucagon receptor agonist - Wikipedia

    en.wikipedia.org/wiki/Glucagon_receptor_agonist

    [3] [4] In healthy people, a low dose of exogenous glucagon increases energy expenditure and reduces energy intake without causing hyperglycemia. [2] Glucagon is often elevated in type 2 diabetes; [3] glucagon receptor antagonists were developed for the treatment of this disease but most were abandoned due to safety and adverse effects. [2]

  7. Liraglutide - Wikipedia

    en.wikipedia.org/wiki/Liraglutide

    Liraglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) also known as incretin mimetics. [6] It works by increasing insulin release from the pancreas and decreases excessive glucagon release. [6] Common side effects include low blood sugar, nausea, dizziness, abdominal pain, and pain at the site of injection.

  8. Route of administration - Wikipedia

    en.wikipedia.org/wiki/Route_of_administration

    Subcutaneous (under the skin). [22] This generally takes the form of subcutaneous injection, e.g. with insulin. Skin popping is a slang term that includes subcutaneous injection, and is usually used in association with recreational drugs. In addition to injection, it is also possible to slowly infuse fluids subcutaneously in the form of ...

  9. Injection site reaction - Wikipedia

    en.wikipedia.org/wiki/Injection_site_reaction

    Injection site reactions (ISRs) are reactions that occur at the site of injection of a drug. They may be mild or severe and may or may not require medical intervention. Some reactions may appear immediately after injection, and some may be delayed. [1] Such reactions can occur with subcutaneous, intramuscular, or intravenous administration.

  1. Ad

    related to: subcutaneous injection sites landmarks for glucagon treatment of hypertension